206 related articles for article (PubMed ID: 31537641)
1. Concomitant
Rodriguez R; Fournier B; Cordeiro DJ; Winter S; Izawa K; Martin E; Boutboul D; Lenoir C; Fraitag S; Kracker S; Watts TH; Picard C; Bruneau J; Callebaut I; Fischer A; Neven B; Latour S
J Exp Med; 2019 Dec; 216(12):2800-2818. PubMed ID: 31537641
[TBL] [Abstract][Full Text] [Related]
2. Immunodeficiency and EBV-induced lymphoproliferation caused by 4-1BB deficiency.
Alosaimi MF; Hoenig M; Jaber F; Platt CD; Jones J; Wallace J; Debatin KM; Schulz A; Jacobsen E; Möller P; Shamseldin HE; Abdulwahab F; Ibrahim N; Alardati H; Almuhizi F; Abosoudah IF; Basha TA; Chou J; Alkuraya FS; Geha RS
J Allergy Clin Immunol; 2019 Aug; 144(2):574-583.e5. PubMed ID: 30872117
[TBL] [Abstract][Full Text] [Related]
3. Activating PIK3CD mutations impair human cytotoxic lymphocyte differentiation and function and EBV immunity.
Edwards ESJ; Bier J; Cole TS; Wong M; Hsu P; Berglund LJ; Boztug K; Lau A; Gostick E; Price DA; O'Sullivan M; Meyts I; Choo S; Gray P; Holland SM; Deenick EK; Uzel G; Tangye SG
J Allergy Clin Immunol; 2019 Jan; 143(1):276-291.e6. PubMed ID: 29800648
[TBL] [Abstract][Full Text] [Related]
4. Signaling pathways involved in the T-cell-mediated immunity against Epstein-Barr virus: Lessons from genetic diseases.
Latour S; Fischer A
Immunol Rev; 2019 Sep; 291(1):174-189. PubMed ID: 31402499
[TBL] [Abstract][Full Text] [Related]
5. Herpesviruses in the Activated Phosphatidylinositol-3-Kinase-δ Syndrome.
Cohen JI
Front Immunol; 2018; 9():237. PubMed ID: 29599765
[TBL] [Abstract][Full Text] [Related]
6. Rapid identification and characterization of infected cells in blood during chronic active Epstein-Barr virus infection.
Fournier B; Boutboul D; Bruneau J; Miot C; Boulanger C; Malphettes M; Pellier I; Dunogué B; Terrier B; Suarez F; Blanche S; Castelle M; Winter S; Delecluse HJ; Molina T; Picard C; Ehl S; Moshous D; Galicier L; Barlogis V; Fischer A; Neven B; Latour S
J Exp Med; 2020 Nov; 217(11):. PubMed ID: 32812031
[TBL] [Abstract][Full Text] [Related]
7. Patients With Natural Killer (NK) Cell Chronic Active Epstein-Barr Virus Have Immature NK Cells and Hyperactivation of PI3K/Akt/mTOR and STAT1 Pathways.
Howe MK; Dowdell K; Kuehn HS; Li Q; Hart GT; Garabedian D; Liepshutz K; Hsu AP; Su H; Niemela JE; Stoddard JL; Uzel G; Shereck E; Schulz L; Feldman T; Rosenzweig SD; Long EO; Dropulic L; Cohen JI
J Infect Dis; 2020 Sep; 222(7):1170-1179. PubMed ID: 32386415
[TBL] [Abstract][Full Text] [Related]
8. CD137 deficiency because of two novel biallelic
Shen K; Wang J; Zhou K; Mu W; Zhang M; Deng X; Cai H; Zhang W; Huang W; Xiao M
Clin Transl Immunology; 2023; 12(5):e1448. PubMed ID: 37144041
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated B-cell lymphoproliferative disorder meeting the definition of CAEBV B cell disease: a case report.
Ma Y; Bao Y; Zheng M
BMC Infect Dis; 2023 Jul; 23(1):453. PubMed ID: 37420238
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological states of Epstein-Barr virus-associated T/NK-cell lymphoproliferative disorders (severe chronic active EBV infection) of children and young adults.
Suzuki K; Ohshima K; Karube K; Suzumiya J; Ohga S; Ishihara S; Tamura K; Kikuchi M
Int J Oncol; 2004 May; 24(5):1165-74. PubMed ID: 15067338
[TBL] [Abstract][Full Text] [Related]
11. Induction of CD137 expression by viral genes reduces T cell costimulation.
Wu M; Wong HY; Lin JL; Moliner A; Schwarz H
J Cell Physiol; 2019 Nov; 234(11):21076-21088. PubMed ID: 31025383
[TBL] [Abstract][Full Text] [Related]
12. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
Gallot G; Hamidou MA; Clémenceau B; Gaschet J; Tiberghien P; Ferrand C; Vivien R; Barbarot S; Coste-Burel M; Moreau A; Vié H
Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
[TBL] [Abstract][Full Text] [Related]
13. Inherited TNFSF9 deficiency causes broad Epstein-Barr virus infection with EBV+ smooth muscle tumors.
Fournier B; Hoshino A; Bruneau J; Bachelet C; Fusaro M; Klifa R; Lévy R; Lenoir C; Soudais C; Picard C; Blanche S; Castelle M; Moshous D; Molina T; Defachelles AS; Neven B; Latour S
J Exp Med; 2022 Jul; 219(7):. PubMed ID: 35657354
[TBL] [Abstract][Full Text] [Related]
14. Inherited Immunodeficiencies With High Predisposition to Epstein-Barr Virus-Driven Lymphoproliferative Diseases.
Latour S; Winter S
Front Immunol; 2018; 9():1103. PubMed ID: 29942301
[TBL] [Abstract][Full Text] [Related]
15. Genetic Defects in Phosphoinositide 3-Kinase δ Influence CD8
Cannons JL; Preite S; Kapnick SM; Uzel G; Schwartzberg PL
Front Immunol; 2018; 9():1758. PubMed ID: 30116245
[TBL] [Abstract][Full Text] [Related]
16. Restricted diversification of T-cells in chronic active Epstein-Barr virus infection: potential inclination to T-lymphoproliferative disease.
Ohga S; Kimura N; Takada H; Nagano M; Ohshima K; Nomura A; Muraoka K; Take H; Yamamori S; Hara T
Am J Hematol; 1999 May; 61(1):26-33. PubMed ID: 10331508
[TBL] [Abstract][Full Text] [Related]
17. When to suspect inborn errors of immunity in Epstein-Barr virus-related lymphoproliferative disorders.
Sacco KA; Notarangelo LD; Delmonte OM
Clin Microbiol Infect; 2023 Apr; 29(4):457-462. PubMed ID: 36209991
[TBL] [Abstract][Full Text] [Related]
18. Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disorder Presenting as Chronic Diarrhea and Intestinal Bleeding: A Case Report.
Wang Y; Li Y; Meng X; Duan X; Wang M; Chen W; Tang T; Li Y
Front Immunol; 2018; 9():2583. PubMed ID: 30519236
[TBL] [Abstract][Full Text] [Related]
19. Epstein-Barr virus-positive cytotoxic T-cell lymphoma followed by chronic active Epstein-Barr virus infection-associated T/NK-cell lymphoproliferative disorder: a case report.
Kato S; Miyata T; Takata K; Shimada S; Ito Y; Tomita A; Elsayed AA; Takahashi E; Asano N; Kinoshita T; Kimura H; Nakamura S
Hum Pathol; 2013 Dec; 44(12):2849-52. PubMed ID: 24012167
[TBL] [Abstract][Full Text] [Related]
20. Dominant-activating germline mutations in the gene encoding the PI(3)K catalytic subunit p110δ result in T cell senescence and human immunodeficiency.
Lucas CL; Kuehn HS; Zhao F; Niemela JE; Deenick EK; Palendira U; Avery DT; Moens L; Cannons JL; Biancalana M; Stoddard J; Ouyang W; Frucht DM; Rao VK; Atkinson TP; Agharahimi A; Hussey AA; Folio LR; Olivier KN; Fleisher TA; Pittaluga S; Holland SM; Cohen JI; Oliveira JB; Tangye SG; Schwartzberg PL; Lenardo MJ; Uzel G
Nat Immunol; 2014 Jan; 15(1):88-97. PubMed ID: 24165795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
